Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand

Patricia Danzon and Jonathan Ketcham

A chapter in Frontiers in Health Policy Research, Volume 7, 2004, pp 1-54 from National Bureau of Economic Research, Inc

JEL-codes: I11 I18 (search for similar items in EconPapers)
Date: 2004
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (44)

Downloads: (external link)
http://www.nber.org/chapters/c9868.pdf (application/pdf)

Related works:
Journal Article: Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand (2004)
Working Paper: Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand (2003)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberch:9868

Ordering information: This item can be ordered from
http://www.nber.org/chapters/c9868

Access Statistics for this chapter

More chapters in NBER Chapters from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().